Attached files
file | filename |
---|---|
10-Q - 090930_IMSC_FORM 10Q - SECURE POINT TECHNOLOGIES INC | imscform10q090930.htm |
EX-32.1 - 090930_IMSC_FORM 10Q_EX 32.1 - SECURE POINT TECHNOLOGIES INC | imscform10q090930_ex32-1.htm |
EX-31.2 - 090930_IMSC_FORM 10Q_EX 31.2 - SECURE POINT TECHNOLOGIES INC | imscform10q090930_ex31-2.htm |
EX-31.1 - 090930_IMSC_FORM 10Q_EX 31.1 - SECURE POINT TECHNOLOGIES INC | imscform10q090930_ex31-1.htm |
Exhibit
32.2
In
connection with the Quarterly Report of Implant Sciences Corporation, a
Massachusetts corporation (the “Company”) on Form 10-Q for the period ended
September 30, 2009, as filed with the Securities and Exchange Commission on the
date hereof (the “Report”), I, Glenn D. Bolduc, President, Chief Executive
Officer and Chief Financial Officer of we, hereby certify, pursuant to 18 U.S.C.
Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of
2002, that, to the best of my knowledge:
(1) The
Report fully complies with the requirements of section 13(a) or 15(d) of the
Securities Exchange Act of 1934; and
(2) The
information contained in the Report fairly presents, in all material respects,
the financial condition and result of operations of we.
/s/ Glenn D.
Bolduc
|
|
Glenn
D. Bolduc
|
|
President,
Chief Executive Officer and Chief Financial Officer
|
|
Date:
November 13, 2009
|
This
certification accompanies each report of we on Form 10-Q and Form 10-K pursuant
to §906 of the Sarbanes-Oxley Act of 2002 and shall not, except to the extent
required by the Sarbanes-Oxley Act of 2002, be deemed filed by we for purposes
of §18 of the Securities Exchange Act of 1934, as amended.
A signed
original of this written statement required by §906 has been provided to we and
will be retained by we and furnished to the Securities and Exchange Commission
or our staff upon request.